The definitive segmentation of the Gastrointestinal Drugs Market Segment is based on the therapeutic class and the mode of action of the drugs, reflecting the evolution of GI pharmacology. The largest revenue segment is the Biologics Segment, which includes monoclonal antibodies (e.g., anti-TNF, anti-integrin) and other large-molecule injectables used exclusively for moderate-to-severe...